These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10680047)

  • 1. Modification of coronary artery disease progression by cholesterol-lowering therapy: the angiographic studies.
    Archbold RA; Timmis AD
    Curr Opin Lipidol; 1999 Dec; 10(6):527-34. PubMed ID: 10680047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of lipid lowering in coronary artery disease.
    Goldberg AC
    Curr Opin Cardiol; 1997 Sep; 12(5):488-93. PubMed ID: 9352177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of cholesterol-lowering therapy: coronary angiographic and events trials.
    Waters D; Pedersen TR
    Am J Med; 1996 Oct; 101(4A):4A34S-38S; discussion 39S. PubMed ID: 8900335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).
    Bestehorn HP; Rensing UF; Roskamm H; Betz P; Benesch L; Schemeitat K; Blümchen G; Claus J; Mathes P; Kappenberger L; Wieland H; Neiss A
    Eur Heart J; 1997 Feb; 18(2):226-34. PubMed ID: 9043838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program.
    Grundy SM; Cleeman JI; Rifkind BM; Kuller LH
    Arch Intern Med; 1999 Aug 9-23; 159(15):1670-8. PubMed ID: 10448768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between hypercholesterolemia, lipid-lowering therapy and coronary flow velocity reserve evaluated by stress transesophageal echocardiography in patients with a negative coronary angiogram.
    Nemes A; Neu K; Forster T; Gruber N; Csanády M
    Echocardiography; 2004 Jan; 21(1):37-41. PubMed ID: 14717719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are we aggressive enough in lowering cholesterol?
    Waters DD
    Am J Cardiol; 2001 Aug; 88(4A):10F-5F. PubMed ID: 11520481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline?
    Jacobson TA
    Ann Intern Med; 2000 Oct; 133(7):549-54. PubMed ID: 11015169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypercholesterolemia and coronary disease: intervention strategies].
    Brunelli C; Spallarossa P; Saccani A; Corsiglia L; Ghigliotti G; Caponnetto S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):303-8. PubMed ID: 1841785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lipid-lowering therapy on total and coronary mortality.
    Holme I
    Curr Opin Lipidol; 1995 Dec; 6(6):374-8. PubMed ID: 8750251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials.
    White CW
    Am J Med; 1998 Jul; 105(1A):63S-68S. PubMed ID: 9707270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
    Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM
    Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
    Stewart BF; Brown BG; Zhao XQ; Hillger LA; Sniderman AD; Dowdy A; Fisher LD; Albers JJ
    J Am Coll Cardiol; 1994 Mar; 23(4):899-906. PubMed ID: 8106695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering interventions in angiographic trials.
    Rossouw JE
    Am J Cardiol; 1995 Sep; 76(9):86C-92C. PubMed ID: 7572693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study.
    Mizuno K; Nakamura H; Ohashi Y; Kaburagi T; Kitabatake A; Tochihara T; Hosoda S;
    Clin Ther; 2004 Jun; 26(6):878-88. PubMed ID: 15262458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholesterol synthesis inhibitors. Clinical studies on lowering coronary risk and plaque stabilization].
    Müller-Wieland D; Faust M; Krone W
    Internist (Berl); 1998 Sep; 39(9):934-42. PubMed ID: 9788115
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholesterol lowering with statins reduces exercise-induced myocardial ischemia in hypercholesterolemic patients with coronary artery disease.
    Ramires JA; Sposito AC; Mansur AP; Coelho OR; Maranhão M; Cesar LA
    Am J Cardiol; 2001 Nov; 88(10):1134-8. PubMed ID: 11703958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of recent clinical trials of lipid lowering in coronary artery disease.
    Smith SC
    Am J Cardiol; 1997 Oct; 80(8B):10H-13H. PubMed ID: 9372993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia.
    West MS; Herd JA; Ballantyne CM; Pownall HJ; Simpson S; Gould L; Gotto AM
    Control Clin Trials; 1996 Dec; 17(6):550-83. PubMed ID: 8974213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.